Profile data is unavailable for this security.
About the company
PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.
- Revenue in TWD (TTM)163.13m
- Net income in TWD-86.82m
- Incorporated1998
- Employees84.00
- LocationPhytohealth Corp5F-1, No.167, Fu Hsing North RoadTAIPEI 105TaiwanTWN
- Phone+886 225453697
- Fax+886 225140245
- Websitehttps://www.phytohealth.com.tw/zh-Hant
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chunghwa Chemical Synthsis&Biotech CoLtd | 1.52bn | 97.62m | 2.97bn | 243.00 | 30.54 | 0.891 | 10.20 | 1.96 | 1.26 | 1.26 | 19.52 | 43.04 | 0.3063 | 0.9709 | 5.92 | -- | 1.97 | 9.03 | 2.27 | 10.56 | 31.22 | 43.26 | 6.44 | 20.15 | 0.9154 | -- | 0.2319 | 24.83 | -1.45 | 15.40 | -43.14 | 2.49 | 36.95 | -7.79 |
| Phytohealth Corp | 163.13m | -86.82m | 3.22bn | 84.00 | -- | 1.67 | -- | 19.72 | -0.4371 | -0.4371 | 0.8213 | 9.72 | 0.0679 | 0.6269 | 4.19 | -- | -5.15 | -5.66 | -6.35 | -7.31 | 39.92 | 47.70 | -75.82 | -92.91 | 31.96 | -- | 0.0088 | -- | 19.95 | 8.62 | 40.67 | -- | -40.76 | -- |
Data as of Nov 22 2024. Currency figures normalised to Phytohealth Corp's reporting currency: Taiwan Dollar TWD
0.73%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 1.20m | 0.61% |
| SSgA Funds Management, Inc.as of 07 Nov 2024 | 219.49k | 0.11% |
| DFA Australia Ltd.as of 30 Sep 2024 | 30.92k | 0.02% |
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
